The molecular pharmacology of doxorubicin in vivo
- 1 May 1991
- journal article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 27 (5), 532-535
- https://doi.org/10.1016/0277-5379(91)90209-v
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicityPharmacology & Therapeutics, 1990
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometryBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1988
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of actionBiochemistry, 1987
- Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-.ANG. resolutionBiochemistry, 1987
- Metabolism and reactions of quinoid anticancer agentsPharmacology & Therapeutics, 1987
- Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drugBritish Journal of Cancer, 1986
- A Chemical Perspective on the Anthracycline Antitumor AntibioticsEnvironmental Health Perspectives, 1985
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984